Skip to main content

Find Clinical Trials

Home
Conditions
Bordetella Infections

Clinical trial condition

Bordetella Infections

Explore clinical trials studying Bordetella Infections. Study availability and eligibility vary by location and protocol.

229 public trials 8 recruiting studies

Refine in advanced search Browse all conditions

Bordetella Infections trial results

Completed

Hepatitis B Vaccination in Infants

NCT01896596

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +29 more
Locations: St George's Vaccien Institute London, United Kingdom

View Trial Details

Completed

A Trial Comparing Two Pertussis-containing Vaccines in Pregnancy and Vaccine Responses in UK Mothers and Their Infants

NCT02145624

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Bordetella Infections, +6 more
Locations: Gloucestershire Gloucestershire, United Kingdom

Hertfordshire Hertfordshire, United Kingdom

St George's Vaccine Institute London, United Kingdom

View Trial Details

Completed

Adacel® Booster Vaccination for CMI Assay Development

NCT04543669

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Bordetella Infections, +6 more
Locations: Canadian Center for Vaccinology Halifax, Nova Scotia, Canada

View Trial Details

Completed

Pertussis Maternal Immunization Study

NCT00553228

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Bordetella Infections, +6 more
Locations: Clinical Trial Research Center - Canadian Center for Vaccinology Halifax, Nova Scotia, Canada

View Trial Details

Completed

Effectiveness of Maternal Immunization With Boostrix at Preventing Pertussis Among Infants <2 Months Old in the United States

NCT03973905

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Bordetella Infections, +5 more
Locations: GSK Investigational Site Wavre, Belgium

View Trial Details

Completed

Long-term Persistence of Hepatitis B and Pertussis Antibody Responses in Healthy 4 to 5 Year Old Children Previously Vaccinated With Vaxelis® or INFANRIX® Hexa (V419-012)

NCT02759354

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Blood-Borne Infections, +16 more
Locations: Not specified

View Trial Details

Completed

Evaluation of an Infant Immunization Encouragement Program in Nigeria

NCT03870061

Conditions: Actinomycetales Infections, Arbovirus Infections, Bacterial Infections, +55 more
Locations: Primary Health Care facilities across Jigawa State Various Cities, Jigawa State, Nigeria

Primary Health Care facilities across Katsina State Various Cities, Katsina State, Nigeria

Primary Health Care facilities across the Zamfara State Various Cities, Zamfara State, Nigeria

View Trial Details

Completed

Seroprevalence of Bordetella Pertussis Antibodies and Anti-pertussis Antibody Response After a Single Dose of Tdap in Pregnant Thai Women

NCT03498300

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Bordetella Infections, +7 more
Locations: Nalat Sompagdee Bangkok Noi, Bangkok, Thailand

View Trial Details

Completed

Viaskin Pertussis Vaccine Trial

NCT03035370

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Bordetella Infections, +5 more
Locations: Center for Vaccinology Medical faculty UNIGE and University of Geneva (HUG) Geneva, Switzerland

View Trial Details

Completed

Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery

NCT02853929

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +37 more
Locations: GSK Investigational Site Carlton, Victoria, Australia

GSK Investigational Site Calgary, Alberta, Canada

GSK Investigational Site Halifax, Nova Scotia, Canada

GSK Investigational Site Montreal, Quebec, Canada

View all 29 locations

View Trial Details